Best Practices, LLC Report Uncovers How Pharma Leaders are Using Omnichannel to Maximize Digital Marketing Assets
CHAPEL HILL, N.C., Apr. 11, 2025/ -- As digital transformation accelerates across healthcare, pharmaceutical companies are revamping their marketing models to align with modern engagement needs.
To understand how top biopharma companies are adapting and excelling in this environment, Best Practices, LLC has released a comprehensive benchmarking report titled "Omnichannel Marketing: Maximize your Digital Marketing Assets."
The 102-page report explores how leading life sciences organizations are utilizing omnichannel strategies to increase reach, improve HCP and patient engagement, and drive stronger ROI from their digital investments.
Drawing insights from 35 executives across 29 biopharma companies, the report delivers critical benchmarks and best practices on:
- Digital marketing structure, staffing, and investment levels
- Innovative tools, mobile and digital health tactics
- Social listening, EHR integration, and IDN outreach
- Performance measurement and KPI standardization
- Digitizing new product planning and launch campaigns
Key findings show that:
- Companies are heavily investing in website management and digital content.
- Social listening is the top tactic for engagement and insight generation.
- Digital leaders are integrating data-sharing partnerships with payers and providers.
This report helps pharma professionals benchmark their digital strategies, prioritize investments, and scale innovation to meet the evolving needs of customers in a post-2020 world.
For a deeper dive, download the complimentary report summary here: https://www.best-in-class.com/rw453.htm"> https://www.best-in-class.com/rw453.htm
Pressed for time? Watch the short video summary below to uncover the key findings and recommendations from the study: